More Botanix Pharmaceuticals Limited news Botanix Pharmaceuticals LimitedASX: BOT Ethics Approval for Phase 2 Atopic Dermatitis Study Received Dec 18, 2018 at 4:05 AM UTC · Issued by Botanix Pharmaceuticals Limited As issuedPlain English Watch Botanix Pharmaceuticals explain it↗Botanix Pharmaceuticals (BXPHF) Q2 2026 Earnings Call · Replay · Mar 2Botanix Pharmaceuticals Ltd has released a press release. View Attachment
